are glp-1 medications safe GLP-1s Safe? Everything You Need to Know About Safety Are Serious Anesthesia Risks of

Description

Shorter-acting agents may exert more pronounced effects on postprandial glucose through transient gastric emptying delay, while longer-acting agents may provide steadier effects on fasting and overall glycemic patterns

This move further strengthens Ingredions position in the fast-growing prebiotics and functional ingredients space

Some may lose more weight, others may lose less

What is changing is the scale and accessibility of the category - not a total shutdown

PMID: Summary Keywords biologic therapy, early psoriatic arthritis, GLP-1 receptor agonists, inflammation, metabolic syndrome, psoriasis Citation Ciancio G, Maranini B, Sandri G, Amati G, Bortoluzzi A, Silvagni E, Govoni M and Giuggioli D (2026) Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities